• Psychology, Medicine
• Published in Psychopharmacology 2011
• DOI:10.1007/s00213-011-2247-y

Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties

@article{NewmanTancredi2011ComparativePO,
  title={Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties},
  author={Adrian Newman-Tancredi and Mark S. Kleven},
  journal={Psychopharmacology},
  year={2011},
  volume={216},
  pages={451-473}
}

• Adrian Newman-Tancredi, Mark S. Kleven

RationaleThere is increasing interest in antipsychotics intended to manage positive symptoms via D2 receptor blockade and improve negative symptoms and cognitive deficits via 5-HT1A activation. Such a strategy reduces side-effects such as the extrapyramidal syndrome (EPS), weight gain, and autonomic disturbance liability.ObjectiveThis study aims to review pharmacological literature on compounds interacting at both 5-HT1A and D2 receptors (as well as at other receptors), including aripiprazole… CONTINUE READING

View on Springer

Alternate Sources

Save to Library

Create Alert

Cite